F]YF 3 nanoparticles for PET imaging
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Experimental section

Materials
Ammonium fluoride, Yttrium(III) chloride hexahydrate, doxorubicin hydrochloride, citric acid, folate, and the other chemicals were purchased from Sigma Aldrich, Inc. and used without purification.
Preparation of YF 3 nanoparticles
In a typical synthesis, a solution of 1 mmol of citric acid in 3.5 mL of distilled water was adjusted with sodium hydroxide to pH 67 and heated to 75 °C. Next, folate (0.1 mmol) was added until the mixture became clear. This was followed by the addition of 0.12 mmol YCl 3 .6H 2 O in 0.2 mL of distilled water and 11 mg of NH 4 F (0.3 mmol) in 0.4 mL of distilled water consecutively. After stirring for 0.5 h, the nanoparticles were precipitated with 5 mL of ethanol and isolated with centrifuge at 14,000 rpm for 15 min. The supernatant was poured off, and the residual supernatant was subsequently washed with ethanol and distilled water three times.
The folate groups on the surface of the FA-YF 3 nanoparticles were quantified by measuring the UV absorption of the FA-YF 3 nanoparticles and subtracting the UV absorption of the Cit-YF 3 nanoparticles at λ=281 nm. To synthesize Cit-YF 3 nanoparticles, the procedure was repeated without folate. To synthesize PEG-YF 3 nanoparticles, substitute FMOC-PEG 2000 -COOH (28 mg) linkage in place of folate.
Preparation of doxorubicin (DOX) linked YF 3 nanoparticles
Aliquots of free DOX in water (0.3 mg in 0.4 mL) were added into an aqueous solution of Cit-YF 3 or FA-YF 3 (3 mg, 0.1 mL), and the mixtures were stirred at room temperature for 24 h. After centrifugation (14,000 rpm for 30 min), the precipitate was washed with ethanol and centrifuged. The washing cycle was repeated until the supernatant became colorless. All supernatants collected were pooled together, and the amount of free DOX in the supernatant was determined by spectrophotometry at 478 nm.
Characterization of YF 3 nanoparticles
The size and morphology of the nanoparticles were investigated using Transmission Electron Microscope (TEM) (FEI Tecnai G2 F20 X-TWIN, 200 kV). TEM samples were prepared by dripping the nanoparticle solution onto a carbon-supported copper grid and drying it at room temperature before observation. Energy-dispersive X-ray analysis (EDXA) of the samples was also performed during TEM measurements. The hydrodynamic size of the nanoparticles was also measured in aqueous solution using a Dynamic Light Scattering (DLS) instrument (Brookhaven 90 Plus Nanoparticle Size Analyzer). The absorption spectra were recorded on an Agilent 8453 UV-Vis spectrometer.
Preparation of [ 18 F]YF 3 nanoparticles
In a typical synthesis, 18 F-fluoride (0.3 mCi/11 MBq)-K 2 CO 3 (5 μg) solution (100 μL) was mixed with nanoparticle solution (100 μL) via vortexing and incubated at room temperature within 10 min. Free by incubation with mouse serum or human serum (1:1, v:v) at 37 ºC for 0.5, 1, 2, 4, 6h, respectively. Free 18 F-fluoride was removed from the nanoparticles by centrifugation.
Cell culture and cytotoxicity assay
PYMT and MDA-MB-468 cell lines were grown in DMEM supplemented with 10% FBS. Cultures were maintained at 37 °C under a humidified atmosphere containing 5% CO 2 .
The in vitro cytotoxicity was measured using the methyl thiazolyl tetrazolium (MTT) assay in MDA-MB-468 cell line. Cells growing in log phase were seeded into a 96-well cell-culture plate at 1×10 4 /well and then incubated for 24 h at 37 °C under 5% CO 2 . Particles or free DOX (100 µL/well) at different concentrations were added to the wells of the treatment group, and 100 µL/well DMEM to the negative control group, respectively. The cells were incubated for 24 h at 37 °C under 5% CO 2 . Subsequently, 10 µL of MTT (5 mg/mL) was added to each well of the 96 well plate and incubated for an additional 4 h at 37 °C under 5% CO 2 . After the addition of DMSO (200 µL/well), the assay plate was allowed to shake at room temperature for 20 min. A Tecan microplate reader was used to measure the OD570 (A value) of each well with background subtraction at 690 nm. The following formula was used to calculate the viability of cell growth: cell viability (%) = (mean of Absorbance value of treatment group / mean of Absorbance value of control)·100.
Cell uptake analysis
Cell uptake studies were performed with the adherent PYMT (high folate receptor expression) and MDA-MB-468 (low folate receptor expression) cells. Cells growing in log phase were seeded into a 12-well cell-culture plate at a density of 1×10 4 /well and then incubated for 24 h at 37 °C under 5% CO 2 . [ 18 F]YF 3 (100 µL/well) was added to the wells of the treatment group. The cells were incubated with at 37 °C under 5% CO 2 for 45 min, 1 h, and 2 h, respectively. The radioactivity was evaluated using a Capintec PET Dose Calibrator.
In vivo lymph node microPET/CT imaging
Sprague-Dawley rats (Charles Rivers) were anesthetized with 3% isoflurane, and intracutaneous injections of ∼50 μL of [ 18 F]YF 3 (∼50 μCi/1.85 MBq) were administrated into the front or rear foot pads. In vivo lymph node imaging was carried out on a microPET/CT system (Siemens-Inveon). The PET imaging was acquired directly following a CT scan of approximately 15 min. A dynamic PET scan was performed from 15 to 45 min, and a 10 min PET static scan was performed at 1 h post-injection. Reconstructed CT and PET images were fused and analyzed using Inveon Research Workplace (IRW) software. 
